1 Phase 3 trials for B-cell Acute Lymphoblastic Leukemia. Phase 3 trials are the final stage of testing before a treatment can be submitted for FDA approval.
What is a Phase 3 trial?
Phase 3 clinical trials study a treatment in large groups (hundreds to thousands of people) to confirm its effectiveness, monitor side effects, and compare it to standard treatments. These trials are the last major step before the FDA considers approving a new treatment.
Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.